Biogen
BIIB
BIIB
1,057 hedge funds and large institutions have $31.7B invested in Biogen in 2020 Q4 according to their latest regulatory filings, with 170 funds opening new positions, 287 increasing their positions, 431 reducing their positions, and 148 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $37.1B → $31.7B (-$5.44B)
33% less repeat investments, than reductions
Existing positions increased: 287 | Existing positions reduced: 431
61% less funds holding in top 10
Funds holding in top 10: 18 → 7 (-11)
Holders
1,057
Holding in Top 10
7
Calls
$1.98B
Puts
$1.64B
Top Buyers
| 1 | +$226M | |
| 2 | +$220M | |
| 3 | +$205M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$136M |
| 5 |
DM
Deerfield Management
New York
|
+$110M |
Top Sellers
| 1 | -$289M | |
| 2 | -$256M | |
| 3 | -$191M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$130M |
| 5 |
KBC Group
Brussels,
Belgium
|
-$114M |